Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Very muted SP response, I suppose unless you know the company the reach announcement doesn't really tell you much about how valuable this is...
Probably need to wait for a real contact RNS before DIM gives us a real boost
The fantastic success of Orph has pushed me well past the £85k of protection you get if a financial institution fails. Do I need to worry about this as very little is cash. I actually own the shares in my account and if IG collapsed I'd still own them and have to move them to a different ISA provider?
No sure what the connection is
https://find-and-update.company-information.service.gov.uk/company/10099653
Just found them and read through them. If the presentations for the Markman hearing represents all of Samsung's defense points then they are truly f**ked, they don't offer anything to explain their use of the very well defined Nanoco process, they are clutching at straws. Each point Samsung makes are valid, but I think they don't really amount to a defence of their use of the process developed by Nanoco.
Monday morning should be very interesting. Tempted to sell more Orph shares to buy more here. Only have a small punt on Nano currently
I'm looking to move money into this share when some others come good (Orph & Nano). Are there any big events or key dates coming up that will affect the SP in the next few months that I'd want to be in before. At this price the company looks fairly safe. Any thoughts?
That page has been there since June 2020 https://www.google.com/search?q=inurl:https://www.nasdaq.com/market-activity/stocks/oporf&cs=0&sxsrf=ALeKk03nnjDcwPCdUP_Ln1IZOLJ7l5-5lw:1614424500797&source=lnt&tbs=qdr:y&sa=X&ved=2ahUKEwigz4v394nvAhVsURUIHY38BGgQpwV6BAgGECQ&biw=1261&bih=2333&dpr=2.75
Moniman who did you find that's accepting spreads on Orph?
There's nothing on the NASDAQ website IPO bit that looks anything like ConserV Biosciences, why would they go on there instead of the UK market?
https://www.nasdaq.com/market-activity/ipos
I was looking on the NASDAQ website for any signs of a upcoming listing for ConserV Biosciences (didn't find any) but did find this about serious competition for Flu-v
https://www.nasdaq.com/articles/3-green-flags-for-novavax-investors-and-1-red-flag-2021-02-20?amp
On the issue of funding, the ConserV Biosciences Covid-19 vaccine is partially government funded. The press release said "Vaccine formulation was funded by the Department of Health and Social Care (DHSC) through an SBRI programme managed by Innovate UK."
That only sounds like early clinical research funding but I'm sure more money would appear from government for the trials phases
If we own 49% of the two main assets we might optimistically get 25-40 % of the shares before the massive dilution caused by the fundraising to fund Flu-v and anything else they want to develop first. What ever we get, I'd just hold on to the free shares and hope one of the vaccine lottery numbers actually comes up. The fund raising would likely Push up the share price if it's after IPO or just give a much higher price at IPO
The universal vaccine technology belongs to seek/PepTcell/ConserV Biosciences and is not part of the imutex assets, Orph only stands to gain from the flu and mosquito Slava vaccines, not wider application like ConserV Biosciences announced recently for universal covid-19 vaccine.
These price movements look like they are trying to fish for trailing stops, watch for a flash drop
Plenty of shares on IG, I get quotes for up to 500,000 @31.7p
...consider the size of this news, what is with this share, never known anything like it
On TV now, on BBC news, not heard Orph or hVivo mentioned yet
Appears on BBC news channel Breaking news banner now
That website has been open since late October